Company intelligence / Profile preview

Optomeditech

Ownership: Private
Development stage: Other

Overview

Optomeditech developed the OptiVein® system, a light-guided intravenous catheter designed to increase the first-attempt success rate for IV cannulation. The device received CE-mark approval and ISO 13485 certification in 2014. Clinical data cited by the company highlight improved patient outcomes and reduced costs due to fewer failed attempts at venous access.

Therapeutic areas: Other
Modalities: Device
Industry: Surgical Medical Devices

Partnerships

Lifeline VenturesSitra, The Finnish Innovation Fund

Beyond the preview

Go deeper on Optomeditech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Optomeditech.

Explore the full profile